PPP2R1A missense mutations as a novel biomarker of response to ATR inhibitors in ARID1A mutant ovarian clear cell carcinoma
Stewart, J., Baxter, J., Zatreanu, D., Brough, R., Song, F., Konde, A., Krastev, D., Alexander, J., Natrajan, R., Banerjee, S., Stephen, P., Lord, C.
Published in European journal of cancer (1990) (01.10.2022)
Published in European journal of cancer (1990) (01.10.2022)
Get full text
Journal Article
3P Identification of novel biomarkers of response to ATR inhibitors in ARID1A mutant ovarian clear cell carcinoma
Stewart, J.R., Baxter, J., Zatreanu, D., Brough, R., Song, F., Konde, A., Krastev, D., Alexander, J., Natrajan, R., Pettitt, S., Banerjee, S., Lord, C.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article